1. Home
  2. Category
  3. Cancer Type

Multiple Myeloma

Genetics & Genomics

Multiple Myeloma: Detecting Genetic Changes Through Bone Marrow Biopsy and the Influence on Care

Donna Catamero
CJON 2018, 22(3), 263-265 DOI: 10.1188/18.CJON.263-265
Knowledge of genetic mutations and how these affect patient outcomes is rapidly expanding in the care of individuals diagnosed with multiple myeloma (MM). Genetic analysis of bone marrow biopsies now provides information about diagnosis, response to treatment, and prognosis. Oncology nurses need to...
0
No votes yet
Read this Article
Supportive Care

Decision Aids: Assisting Patients With Multiple Myeloma and Caregivers With Treatment Decision Making

Bojan Kojovic
Joseph D. Tariman
CJON 2017, 21(6), 660-664 DOI: 10.1188/17.CJON.660-664
A consolidated evaluation of resources on treatment decision aids (DAs) for multiple myeloma (MM) is lacking in the literature. This review identified 29 published DAs. Further analysis of these DAs revealed that the personal values and preferences of patients with MM are not well integrated into...
0
No votes yet
Read this Article
Article

Patient and Healthcare Provider Education Tip Sheets

CJON 2017, 21(5), X1-X27 DOI:
Patients with multiple myeloma (MM) often deal with short- and long-term side effects of the treatment and disease sequelae. Reasons for inadequately managed symptoms are multifactorial. Patient and healthcare provider educational tip sheets that appear throughout this supplement are grouped...
0
No votes yet
Read this Article
CNE Article

Disease and Symptom Care: A Focus on Specific Needs of Patients With Multiple Myeloma

Beth Faiman
CJON 2017, 21(5), 3-6 DOI: 10.1188/17.CJON.S5.3-6
Patients with multiple myeloma (MM) often deal with short- and long-term side effects of the treatment and disease sequelae. Reasons for inadequately managed symptoms are multifactorial (e.g., the patient may fear treatment interruption, the clinician does not assess or address the symptoms) and...
0
No votes yet
Read this Article
CNE Article

Heart and Lung Complications: Assessment and Prevention of Venous Thromboembolism and Cardiovascular Disease in Patients With Multiple Myeloma

Kimberly Noonan
Sandra Rome
Beth Faiman
Daniel Verina
and the International Myeloma Foundation Nurse Leadership Board
CJON 2017, 21(5), 37-46 DOI: 10.1188/17.CJON.S5.37-46
Background: Venous thromboembolism (VTE) and cardiovascular (CV) disease can occur in patients with multiple myeloma. Although VTE and CV disease are separate medical conditions, they can be serious and even life-threatening. Objectives: The objectives of this article are to describe risk factors...
0
No votes yet
Read this Article

Related e-Books

View More

Questions, Concerns or Requests

We're just a click away for assistance.